Wikipedia

Biotronik

Biotronik (BIOTRONIK SE & Co. KG;[1][2] Biotronik Worldwide) is a limited partnership[1] multi-national cardiovascular biomedical research and technology company, headquartered in Berlin, Germany.

BIOTRONIK SE & Co. KG[1]
Company typeLimited partnership[1]
Industry
Cardiovascular
Medical equipment, Medical technology
Founded1963; 61 years ago (1963), in Germany
FoundersMax Schaldach,
Otto Franke
HeadquartersWoermannkehre 1, 12359, Berlin, Germany[1][2]
Number of locations
Manufacturing
Germany, Switzerland, USA, Singapore
Area served
Worldwide
Key people
Lothar Krings,
Joachim Langer,
Ralf Lieb
ProductsMedical devices
487 million Euro, 50% in Europe (2010)
Number of employees
~9,000 (2019)
Websitewww.BIOTRONIK.com

The company offers equipment for diagnosis, treatment, and therapy support in the areas of cardiac rhythm management, electrophysiology, and vascular intervention.[3] In the area of cardiac rhythm management, Biotronik Home Monitoring uses tele-monitoring technology to provide doctors with up-to-date information for implant patients.[4]

Biotronik employs more than 9,000 people worldwide in over 100 countries, with research and development activities in Europe, North America, and Singapore. It produces all critical components of its products in-house. One in every five employees at its Berlin headquarters works in research and development (R&D).[citation needed]

History edit

BIOTRONIK began with the development of the first German implantable pacemaker (Biotronik IP-03) in 1963. The pacemaker was developed at the Technical University of Berlin by physicist Professor. Dr. Max Schaldach (1936–2001[5]),[6][7] a professor of biomedical technology at the Friedrich-Alexander-University of Erlangen-Nuremberg (FAU),[8] and electrical engineer Otto Franke. In the early years, the company worked to improve pacemakers' capacity and battery life, and secure the connections among electrodes, pacemakers, and the heart. Since its start, more than 19 million BIOTRONIK devices in over 100 countries have been implanted.[citation needed]

In 1976, the company moved to Sieversufer 8 in Berlin-Neukölln. In 1979, a US production site in Lake Oswego, Oregon was built. This subsidiary resulted from the acquisition of the American pacemaker producer Stimulation Technology, Inc. At the same time, with the development and production of advanced hybrid circuitry and structural components for the medical technology industry, the company also began to develop circuits for pacemakers. In the 1980s, the dual-chamber stimulation method (DDD) was developed, leading to the manufacturing of a pacemaker that could read and react to spontaneous contractions of the atrium, and better respond to them of its own accord. To this end, BIOTRONIK developed the Diplos 03, a multi-programme DDD pacemaker with bilateral telemetry, which made it a European market leader and increased its presence in South America and Asia.

In 1987, the firm moved its headquarters to Woermannkehre 1, next door to its previous location. In 1993, BIOTRONIK produced the first German implantable cardioverter defibrillator (ICD), among them the Phylax 06. Closed loop stimulation (CLS), which integrates the pacemaker into the body's own regulatory system, thereby allowing it to react to patients’ changing physical and emotional activity, was introduced in the 1990s. Also in 1993, BIOTRONIK developed fractal coating for implantable electrodes. This coating optimises the electrically active surface of the electrode, thereby improving its perception and stimulation properties. BIOTRONIK remains the only manufacturer of fractal-coated electrodes.

 
BIOTRONIK in the Czech Republic, 2011.

In 1994 and 1995 respectively, BIOTRONIK began offering a full spectrum of electrophysiology products and vascular intervention products. BIOTRONIK also develops and produces balloon catheters and stents for the treatment of coronary artery disease. With Philos, the company has offered a complete pacemaker family with telemetry since 2000, when it received CE Mark approval for the product, and also successfully implanted the first pacemaker with Home Monitoring (remote patient monitoring). Home Monitoring has shown significant clinical benefits, including over a 50% reduction in mortality of heart failure patients.[9]

With the Lumax 540 VR-T DX in 2010, BIOTRONIK launched the first and only single-chamber defibrillator with comprehensive atrial diagnostics worldwide. Additionally, the company entered into an exclusive international distribution partnership with the Swiss medical technology company Endosense to distribute their ablation catheter TactiCath with optical contact force. The following year, BIOTRONIK released Orsiro to the market, the world's first hybrid drug-eluting stent with a bio-absorbable coating, adding to innovative treatment options combatting coronary artery disease.[citation needed]

In 2011, BIOTRONIK was the subject of an investigation by the United States Department of Justice (US DoJ) into payments made to doctors in Nevada, United States, who use the company's products in their practices.[10] The case was settled in 2014.[11] In 2013, a similar investigation began and was settled involving payments to physicians in Oregon.[12][13]

 
The former Postfuhramt, acquired in 2012 by BIOTRONIK.

In 2012, the company acquired the old Postfuhramt, a historical brick postal building on Berlin's Oranienburger Strasse in the sub-neighbourhood of Spandauer Vorstadt, in the district of Mitte.[14]

The following year, BIOTRONIK launched BioMonitor, a type of mini ECG device that offers continuous monitoring and daily remote data collection. In addition, BIOTRONIK also developed the world's first series of implantable defibrillators that enable patients, including those suffering heart failure, to undergo MRI scans under certain conditions. BIOTRONIK's ProMRI® technology includes systems approved for 1.5 T and 3.0 T MR scanning, as well as full-body scanning. The company offers the broadest portfolio of pacemakers, defibrillators, and therapies approved to undergo MRIs, with more than 1,000,000 ProMRI® devices and leads implanted worldwide.[15] To navigate through this portfolio, BIOTRONIK invented two online tools in 2016 and 2017; the ProMRI®SystemCheck and ProMRI®Configurator, correspondingly.

For radiation protection, BIOTRONIK distributes the Zero-Gravity Radiation Protection System, which consists of a movable suspended body and head shield. The shield material has a significantly higher lead equivalency than traditional radiation apparel, thereby reducing radiation exposure by 87–100%.[16]

Indicated to treat peripheral artery disease in the lower limbs, BIOTRONIK released the Passeo-18 Lux in 2014 as the first peripheral drug-coated balloon. The year following, CardioMessenger Smart was launched, its new patient device for Home Monitoring,[17] and BioMonitor 2, the second-generation insertable cardiac monitor.[18]

In February 2016, BIOTRONIK Inc. opened an Education and Innovation Center, a training facility and meeting location in New York City.[19]

Awards edit

In 2007, BIOTRONIK was given the EuroPCR 2007 Novelty Award for its innovative absorbable metal stents (AMS) by the European Association of Percutaneous Cardiovascular Interventions (EAPCI). In 2009, it was nominated for the German Future Prize for its Home Monitoring system by the German Federal Ministry of Education and Research. In 2010, BIOTRONIK endowed the Berlin-Brandenburg Academy of Sciences and Humanities' Technical Science Prize, first awarded to Till Schlösser. The CARDIOSTIM Innovation Award for Practice Improvement was granted to BIOTRONIK for its MRI AutoDetect.[20]

Partnerships edit

BIOTRONIK partners with the EPIC Alliance, a global network of female electrophysiologists, in aims to increase collaboration and support for women in the field of electrophysiology.

Business focus edit

  • Cardiac rhythm management: pacemakers, implantable defibrillators, electrodes, cardiac monitors, external monitoring and programming devices
  • Electrophysiology: products for electrophysiological examinations and therapy, including ablation and diagnostic catheters
  • Vascular intervention: products for coronary and peripheral functions including stent systems, balloon catheters and guide wires

Headquarters and locations edit

Europe & Middle East edit

Germany
Austria
Belgium
Czech Republic
Denmark
France
Israel
  • Kohav Yair
Italy
Netherlands
Poland
Spain
Switzerland
  • Baar
  • Bülach, manufacturing of stents and balloon catheters
United Kingdom

Asia edit

North America edit

South America edit

Oceana edit

  • Pymble, New South Wales, Australia

Products and therapies edit

 
BIOTRONIK ICS 3000 and PK-199
  • Bradycardia therapy
    • Pacemakers (Edora, Evity, Enitra, Enticos, Eluna, Epyra, Etrinsa, Evia, Entovis)
    • Electrodes (Solia, Safio S, Siello, Setrox, Selos)
  • Tachycardia therapy
    • Defibrillators (Rivacor, Acticor, Intica NEO, Ilivia, Inventra, Iperia, Idova, Ilesto,)
    • Electrodes (Linox smart, Protego, Plexa)
  • Electrophysiology
    • Ablation catheters (AlCath Flux eXtra Gold, AlCath Flutter, AlCath)
    • Steerable diagnostic catheters (ViaCath)
    • External devices (Qubic RF, Qubic Stim, Qiona)
  • Cardiac resynchronization
    • CRT defibrillators (Ilivia, Inventra, Ipera, Idova, Ilesto,)
    • CRT pacemakers (Edora, Evity, Enitra, Enticos, Eluna, Epyra, Etrinsa, Entovis, Evia)
    • Electrodes (Corox OTW, Sentus OTW BP, Sentus OTW QP, Sentus OTW QP xx/49)
    • Lead systems and accessories (Selectra, ScoutPro, ScoutPro IC)
    • Guide wires (Streamer, VisionWire)
  • Coronary vascular intervention
    • Bio-resorbable scaffold (Magmaris)
    • Drug-eluting stent system (Orsiro)
    • Balloon-expanding cobalt chromium coronary stent systems (PRO-Kinetic Energy, PK Papyrus)
    • Drug-releasing balloon catheter (Pantera Lux)
    • Balloon catheters (Pantera Pro, Pantera, Pantera LEO, AngioSculpt)
    • Guide wires (Cruiser, Galeo Pro, Galeo Magnum)
    • Accessories (3Flow, Neptune Pad)
  • Peripheral vascular intervention
    • Balloon-expanding stent systems (Dynamic, Dynamic Renal, PRO-Kinetic Energy Explorer),
    • Self-expanding stent systems (Astron, Astron Pulsar, Pulsar-18, Pulsar-35)
    • Balloon catheters (Passeo-18 Lux, Passeo-35, Passeo-35 HP, Passeo-14, Passeo-18),
    • Guide wires (Cruiser-18, Cruiser)
    • Introducer sheaths (Fortress)
  • Insertable cardiac monitor (BioMonitor 2, BioMonitor)
  • External devices (Renamic, Reocor, ICS 3000, Reliaty)
  • Patient devices for Home Monitoring (Cardio Messenger, CardioMessenger 2, CardioMessenger Smart)

References edit

  1. ^ a b c d e "BIOTRONIK – Imprint". www.BIOTRONIK.com. BIOTRONIK. Retrieved 26 August 2021.
  2. ^ a b "BIOTRONIK SE & Co. KG – company profile". www.Hoovers.com. D&B Hoovers. Retrieved 26 August 2021.(subscription required)
  3. ^ "BIOTRONIK SE & Co KG - Company Profile and News". Bloomberg.com. Retrieved 2024-03-27.
  4. ^ Biotronik, BO (2007-09-07). "Su corazón en manos seguras" [Your heart in safe hands]. Scribd (in Spanish). Retrieved 2024-03-27.
  5. ^ Lüderitz, Berndt (August 2001). "Max Schaldach 1936-2001: Clinical research in cardiology: official journal of the German Cardiac Society". Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 90 (8): 596–597. doi:10.1007/s003920170130. ISSN 1861-0684.
  6. ^ "Our people". www.biotronik.com. Retrieved 2024-03-27.
  7. ^ "Was ist und wie funktioniert CRT und Home Monitoring?" [What is and how does CRT and home monitoring work?] (PDF). Herz-Blatt: Die Informationsbroschüre für unsere Patienten (in German). Herz Charite: 9. February 2008.
  8. ^ Lemke, Bernd (2024-03-01). "Geschichte der Herzschrittmacher-Therapie in Deutschland". Herzschrittmachertherapie + Elektrophysiologie (in German). 35 (1): 18–54. doi:10.1007/s00399-024-01010-4. ISSN 1435-1544. PMC 10924011. PMID 38421397.
  9. ^ Hindricks, Gerhard; Taborsky, Milos; Glikson, Michael; Heinrich, Ullus; Schumacher, Burghard; Katz, Amos; Brachmann, Johannes; Lewalter, Thorsten; Goette, Andreas; Block, Michael; Kautzner, Josef; Sack, Stefan; Husser, Daniela; Piorkowski, Christopher; Søgaard, Peter; IN-TIME study group (16 August 2014). "Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial". The Lancet. 384 (9943): 583–590. doi:10.1016/S0140-6736(14)61176-4. PMID 25131977. S2CID 5509510. Retrieved 22 April 2016.
  10. ^ Meier, Barry (2 April 2011). "Tipping the odds for a maker of heart implants". www.NYTimes.com. International New York Times.
  11. ^ "Lake Oswego medical device firm, BIOTRONIK, will settle federal kickback claims for $4.9 million". OregonLive.com. 7 November 2014. Retrieved 22 April 2016.
  12. ^ Budnick, Nick (6 August 2013). "Groundbreaking Oregon DOJ cases target doctors' failure to inform patients about device payments". OregonLive.com.
  13. ^ "Oregon DOJ case means doctors could tell patients ties to drug, implant makers". OregonLive.com. 17 August 2013. Retrieved 22 April 2016.
  14. ^ "Neuer Investor - alte Probleme für C/O Berlin". Der Tagesspiegel Online (in German). Retrieved 2021-05-06.
  15. ^ "About ProMRI". BIOTRONIK.com. Retrieved 24 March 2017.
  16. ^ "Zero-Gravity fact sheet" (PDF). BIOTRONIK.com. Retrieved 24 March 2017.
  17. ^ "BIOTRONIK CardioMessenger Smart shares pacemaker and ICD data with cardiologists". MedGadget.com. Retrieved 22 April 2016.
  18. ^ "BIOTRONIK's BioMonitor 2 implantable wireless ECG recorder approved in Europe". MedGadget.com. Retrieved 22 April 2016.
  19. ^ "BIOTRONIK opens state-of-the-art Education and Innovation Center in New York City". www.BusinessWire.com (Press release). Business Wire. 24 February 2016. Retrieved 24 March 2017.
  20. ^ "CARDIOSTIM Innovation Awards". www.CARDIOSTIM.com. Archived from the original on 24 March 2017. Retrieved 23 March 2017.

External links edit

 
Wikimedia Commons has media related to Biotronik.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Biotronik&oldid=1215818134"